Overt Bio

Developer of cell therapies to treat solid tumors

placeNew York City, New York, United States calendar_todayFounded 2022 language overt.bio

Innovation

2 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace active. Cited 70 times.

YearFilings
20252

Social engagement

Social engagement: 1.9K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include Artis Ventures, Wing Venture Capital.

Investor typeCountShare
Venture capital770%
Other / undisclosed330%
Coming soon